Indo Us Bio-Tech Ltd has reported financial results for the period ended September 30, 2020.
Financial Results (H1 FY20-21)
The company has reported net sales of Rs.16.87 crores during the 6 months period ended September 30, 2020 as compared to Rs.21.74 crores during the period ended March 31, 2020.
The company has posted net profit of Rs.1.48 crores for the 6 months period ended September 30, 2020 as against Rs.1.32 crores for the 6 months period ended March 31, 2020.
The company has reported EPS of Rs.2.44 for the 6 months period ended September 30, 2020 as compared to Rs.2.18 for the 6 months period ended March 31, 2020.
Total Income | ₹ 16.87 crs | ₹ 21.74 crs | -22.4% |
Net Profit | ₹ 1.48 crs | ₹ 1.32 crs | 12.12% |
EPS | ₹ 2.44 | ₹ 2.18 | 11.93% |
Financial Results (H1 FY20-21) - YoY ComparisonThe company has reported net sales of Rs.16.87 crores during the 6 months period ended September 30, 2020 as compared to Rs.18.02 crores during the 6 months period ended September 30, 2019.
The company has posted net profit of Rs.1.48 crores for the 6 months period ended September 30, 2020 as against Rs.1.21 crores for the 6 months period ended September 30, 2019.
The company has reported EPS of Rs.2.44 for the 6 months period ended September 30, 2020 as compared to Rs.2 for the 6 months period ended September 30, 2019.
Total Income | ₹ 16.87 crs | ₹ 18.02 crs | -6.38% |
Net Profit | ₹ 1.48 crs | ₹ 1.21 crs | 22.31% |
EPS | ₹ 2.44 | ₹ 2 | 22% |
Source : Equity Bulls
Keywords